Cephalosporin drugs are bactericidal beta lactam antibiotics. These prevent the growth of bacteria by inhibiting cell wall synthesis, which effective in both type of bacteria i.e., gram-positive and gram-negative. Cephalosporin was first prepared from a fungus named Cephalosporium acremonium by scientist Dr. Abraham in 1948. Cephalosporin drugs are considered broad-spectrum antibiotics having similar activities to those of ampicillin and often are considered an alternative to penicillin for many patients. Cephalosporin drugs are used to treat infections in different parts of the body such as lungs, ears, sinuses, nose, throat, and skin. Physicians also prescribe these drugs to treat pneumonia, staph infections, bronchitis, strep throat, tonsillitis, and gonorrhea. Cephalosporin drugs can be classified into five classes or generation depending upon antimicrobial activity. The gram-negative antimicrobial property significantly increases with each newer generation of cephalosporin. Hence, usage of cephalosporin in various disease conditions is likely to boost the growth of the global cephalosporin drugs market in the near future. These drugs are contraindicated in patients who are allergic to them or who have had an anaphylactic reaction to penicillin.

The global cephalosporin drugs market is expected to grow substantially due to increasing demand for anti-microbial in various indications, rising research and development activities, growing awareness among patients, increasing prevalence of infectious diseases, and special regulatory designation for pipeline molecule. Every year, November 18 is celebrated as the European Antibiotic Awareness Day, which helps to increase awareness about antibiotic resistance and promotes judicious use of antibiotics. Such programs about the disease and treatment options increase the treatment-seeking population, thereby boosting the growth of the market. Additionally, low investment in R&D, stringent government policies, and generic saturation of these drugs fuel the growth of the market. Moreover, increasing mergers and acquisitions, use of combination therapies for treatment, and development of safe and highly efficient cephalosporin drugs are other factors likely to contribute to the growth of the market. However, weak pipeline molecules, development of drug resistance and resistance by governments on drug development are some challenges in the global cephalosporin drugs market.

The cephalosporin drugs market has been segmented based on spectrum of antimicrobial activity and route of administration. In terms of spectrum of antimicrobial activity, the market has been segmented into first generation, second generation, third generation, fourth generation, and fifth generation. First generation cephalosporin generates higher revenue than others due to its effectiveness against gram-positive bacteria such as streptococci and staphylococci. These also have gram-negative spectrum antimicrobial activity. Based on route of administration, the market has been segmented into injection and oral. Injection is the most preferred route of drug administration due to quick drug delivery.

Geographically, the global cephalosporin drugs market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region is sub-divided into countries such as the U.S., Canada, Germany, the U.K., Brazil, China, India, Japan, and GCC Countries. Asia Pacific dominated the global cephalosporin drugs market because of increasing awareness about cephalosporin drugs among patients, rising demand for highly developed health care infrastructure, and large population with infectious diseases. North America is considered to be the most attractive market due to rising prevalence of infectious diseases.

Key players operating in the cephalosporin drugs market are Astellas, Roche, Bristol-Myers Squibb, Lupin Pharmaceuticals, Glaxo SmithKline, Pfizer, Abbott, Ranbaxy, Merck, Sandoz, and Teva Pharmaceuticals, among others. In order to gain competitive advantage in the industry, major players are actively involved in various growth strategies. Collaborations, agreements, partnerships, and new product launches are some of the important strategies adopted by the market players.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Cephalosporin Drugs Market

Pre Book